LOGAN MEYERS: Open Payments
NPI 1366926842 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,120 in 60 payments from 17 companies in 2025. Trend: 2023 $64 · 2024 $420 · 2025 $1,120
Food & beverage: $1,120
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $287 |
| AstraZeneca Pharmaceuticals LP | 6 | $183 |
| Novo Nordisk Inc | 13 | $168 |
| PFIZER INC. | 4 | $72 |
| Janssen Pharmaceuticals, Inc | 2 | $55 |
| Lilly USA, LLC | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| Exact Sciences Corporation | 2 | $40 |
| Kowa Pharmaceuticals America, Inc. | 2 | $39 |
Products named: QULIPTA, FARXIGA, Rybelsus, Ozempic, SPRAVATO, NURTEC ODT, MOUNJARO, REXULTI.
Industry payments across MI — which companies pay providers there.
